Patents Assigned to Marantech Holding, LLC
-
Publication number: 20060105057Abstract: Pharmaceutical compositions including tetrasilver tetroxide (Ag4O4), such as in crystalline form, and methods of using such compositions for the prevention, treatment, and management various of dermatological skin conditions and diseases. In one embodiment, these compositions are substantially free of added persulfates. These dermatological conditions and diseases that may be prevented, treated, or managed with the compositions of the invention vary and include, but are not limited to, eczema, psoriasis, dermatitis, disease-induced skin ulcers, undefined tropical diseases, shingles, rashes, bedsores, cold sores, blisters, boils, herpes simplex, acne, pimples, skin chafing, skin cracking, itchiness, skin peeling, and warts.Type: ApplicationFiled: December 27, 2005Publication date: May 18, 2006Applicant: Marantech Holding, LLCInventor: Marvin Antelman
-
Publication number: 20040265877Abstract: The invention is directed to methods for detecting, monitoring and/or diagnosing aberrant cellular proliferation, and disorders associated therewith, such as cancer, and/or infection by microorganisms. The detection, monitoring and/or diagnosis comprises contacting a compound of the invention with a cell or fluid sample. Compound binding confirms the presence of an abnormal cell or a protein associated with an abnormal cell or infection by one or more microorganisms, and/or disorders associated with infection by one or more microorganisms.Type: ApplicationFiled: April 28, 2004Publication date: December 30, 2004Applicant: Marantech Holding, LLCInventors: Marvin S. Antelman, Perry W. Antelman
-
Publication number: 20040022868Abstract: Pharmaceutical compositions including tetrasilver tetroxide (Ag4O4), such as in crystalline form, and methods of using such compositions for the prevention, treatment, and management various of dermatological skin conditions and diseases. In one embodiment, these compositions are substantially free of added persulfates. These dermatological conditions and diseases that may be prevented, treated, or managed with the compositions of the invention vary and include, but are not limited to, eczema, psoriasis, dermatitis, disease-induced skin ulcers, undefined tropical diseases, shingles, rashes, bedsores, cold sores, blisters, boils, herpes simplex, acne, pimples, skin chafing, skin cracking, itchiness, skin peeling, and warts.Type: ApplicationFiled: July 31, 2003Publication date: February 5, 2004Applicant: Marantech Holding LLCInventor: Marvin S. Antelman
-
Patent number: 6669966Abstract: Skin-growth-enhancing compounds and compositions including a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which has a first valence state and at least one of which has a second, different valence state. Preferred compounds include Bi(III,V) oxide, Co(II,III) oxide, Cu(I,III) oxide, Fe(II,III) oxide, Mn(II,III) oxide, and Pr(III,IV) oxide, and Ag(I,III) oxide, or a combination thereof. These compounds may be in a crystalline state having metallic cations of two different valences, or electronic states, in the inorganic crystal. Also included are articles containing such compositions, such as wound dressings, and methods for facilitating or enhancing skin growth using these compounds, compositions, and articles, such as for the treatment or management of burns or skin grafts.Type: GrantFiled: October 20, 2000Date of Patent: December 30, 2003Assignee: Marantech Holding LLCInventor: Marvin S. Antelman
-
Patent number: 6645531Abstract: The present invention is directed to pharmaceutical compositions that include a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which has a first valence state and at least one of which has a second, different valence state. Preferred compounds include Bi(III,V) oxide, Co(II,III) oxide, Cu(I,III) oxide, Fe(II,III) oxide, Mn(II,III) oxide, and Pr(III,IV) oxide, and optionally Ag(I,III) oxide. These compounds may be in a crystalline state having metallic cations of two different valences, or electronic states, in the inorganic crystal. In addition, the invention relates to methods for prevention, management, or treatment of a condition using these compounds or pharmaceutical compositions including the same.Type: GrantFiled: October 20, 2000Date of Patent: November 11, 2003Assignee: Marantech Holding LLCInventor: Marvin S. Antelman
-
Patent number: 6579541Abstract: The invention relates to a method and composition for destroying or inhibiting proliferation of microbes using oxidative fluorinator compounds. Fluoride salts that do not dissociate completely in aqueous solutions, such as tri- or tetravalent transition metal fluorides, inert gas fluorides, or tri- or tetravalent rare earth fluorides, are effective antimicrobial agents even at levels up to about 20 ppm, when used alone or in conjunction with a strong oxidizer.Type: GrantFiled: March 16, 2001Date of Patent: June 17, 2003Assignee: Marantech Holding, LLCInventor: Marvin S. Antelman
-
Patent number: 6436420Abstract: Fibrous textile articles possessing enhanced antimicrobial properties are prepared by the deposition or interstitial precipitation of tetrasilver tetroxide (Ag4O4) crystals within the interstices of fibers, yarns and/or fabrics forming such articles.Type: GrantFiled: January 5, 2000Date of Patent: August 20, 2002Assignee: Marantech Holding, LLCInventor: Marvin S. Antelman
-
Patent number: 6258385Abstract: The invention relates to the use of electron active molecular crystals comprising tetrasilver tetroxide (Ag4O4) for the treatment and cure of dermatological skin conditions (diseases) ranging from dermatitis, acne and psoiasis to herpes and skin ulcers.Type: GrantFiled: April 18, 2000Date of Patent: July 10, 2001Assignee: Marantech Holding, LLCInventor: Marvin S. Antelman
-
Patent number: 6228491Abstract: Fibrous textile articles possessing enhanced antimicrobial properties are prepared by the deposition or interstitial precipitation of cobalt (II, III) oxide (Co3O4) crystals within the interstices of fibers, yarns and/or fabrics forming such articles.Type: GrantFiled: April 4, 2000Date of Patent: May 8, 2001Assignee: Marantech Holding, LLCInventor: Marvin S. Antelman